A nano-cocktail of the PARP inhibitor talazoparib and CDK inhibitor dinaciclib for the treatment of triple negative breast cancer
Article in Cancer Nanotechnology (March 2024)
The most recent citing publications are shown below. View all 18 publications that cite this research output on Dimensions.
Article in Cancer Nanotechnology (March 2024)
Article in Advanced Science (March 2024)
Article in Discover Oncology (January 2024)